Strata Skin Sciences (Strata Skin Sciences) Days Sales Outstanding : 48.53 (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Strata Skin Sciences Days Sales Outstanding?

Strata Skin Sciences's average Accounts Receivable for the three months ended in Dec. 2023 was $4.62 Mil. Strata Skin Sciences's Revenue for the three months ended in Dec. 2023 was $8.69 Mil. Hence, Strata Skin Sciences's Days Sales Outstanding for the three months ended in Dec. 2023 was 48.53.

The historical rank and industry rank for Strata Skin Sciences's Days Sales Outstanding or its related term are showing as below:

SSKN' s Days Sales Outstanding Range Over the Past 10 Years
Min: 37.53 Med: 43.32 Max: 57.94
Current: 48.26

During the past 13 years, Strata Skin Sciences's highest Days Sales Outstanding was 57.94. The lowest was 37.53. And the median was 43.32.

SSKN's Days Sales Outstanding is ranked better than
71.5% of 807 companies
in the Medical Devices & Instruments industry
Industry Median: 63.94 vs SSKN: 48.26

Strata Skin Sciences's Days Sales Outstanding increased from Dec. 2022 (34.97) to Dec. 2023 (48.53).

Strata Skin Sciences Days Sales Outstanding Historical Data

The historical data trend for Strata Skin Sciences's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Strata Skin Sciences Days Sales Outstanding Chart

Strata Skin Sciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

44.95

57.94

38.82

39.89

48.75

Strata Skin Sciences Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															34.97	50.71	46.13	47.43	48.53

Competitive Comparison of Strata Skin Sciences's Days Sales Outstanding

For the Medical Devices subindustry, Strata Skin Sciences's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Strata Skin Sciences's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Strata Skin Sciences's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Strata Skin Sciences's Days Sales Outstanding falls into.

Strata Skin Sciences Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Strata Skin Sciences's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (4.471	+	4.44)	/	2 )	/	33.358	*	365
=	4.4555					/	33.358	*	365
=	48.75

Strata Skin Sciences's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (4.802	+	4.44)	/	2 )	/	8.689	*	365 / 4
=	4.621					/	8.689	*	365 / 4
=	48.53

Strata Skin Sciences (NAS:SSKN) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Strata Skin Sciences Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Strata Skin Sciences's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Strata Skin Sciences (Strata Skin Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Strata Skin Sciences Inc (NAS:SSKN) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

E2OM:Germany E2OM:Germany

Address

5 Walnut Grove Drive, Suite 140, Horsham, PA, USA, 19044

Website

https://www.strataskinsciences.com

Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United states.

Executives

Shmuel Gov	officer: SVP & General Manager Carlsbad	5 WALNUT GROVE DRIVE, STE. 140, HORSHAM PA 19044
Samuel Rubinstein	director	5 WALNUT GROVE DR., SUITE 140, HORSHAM PA 19044
Wayne Cafran	director	5 WALNUT GROVE DRIVE, SUITE 140, HORSHAM PA 19044
Irit Yaniv	director	5 WALNUT GROVE DRIVE, SUITE 140, HORSHAM PA 19044
22nw Gp, Inc.	10 percent owner	1455 NW LEARY WAY, SUITE 400, SEATTLE WA 98107
22nw Fund Gp, Llc	10 percent owner	1455 NW LEARY WAY, SUITE 400, SEATTLE WA 98107
Aron R. English	10 percent owner	1455 NW LEARY WAY, SUITE 400, SEATTLE WA 98107
22nw, Lp	10 percent owner	590 1ST AVE S, UNIT C1, SEATTLE WA 98104
22nw Fund, Lp	10 percent owner	1455 NW LEARY WAY, SUITE 400, SEATTLE WA 98107
Christopher Lesovitz	officer: Chief Financial Officer	5 WALNUT GROVE DRIVE, STE. 140, HORSHAM PA 19044
Robert Joseph Moccia	director, officer: Chief Executive Officer	5 WALNUT GROVE DRIVE, SUITE 140, HORSHAM PA 19044
William D. Humphries	director	C/O STRATA SKIN SCIENCES, INC., 5 WALNUT GROVE DRIVE SUITE 140, HORSHAM PA 19044
Patricia S Walker	director	5540 EKWILL ST STE D, SANTA BARBARA CA 93111
Douglas Strang	director	5 WALNUT GROVE DRIVE, STE. 140, HORSHAM PA 19044
Nachum Shamir	director	12212 TECHNOLOGY BLVD, AUSTIN TX 78727